Indee Labs
San Francisco
About Indee Labs
Indee Labs is developing hardware for gene delivery. Our hardware is uniquely positioned for the efficient development and scalable manufacture of gene-modified cell therapies such as chimeric antigen receptor T cells. The technology is being developed with the help of the Australian National Fabrication Facility. We are alumni of NSW Health, IndieBio, Y Combinator and MBC Biolabs (née QB3@953). We are opening up an office in Sydney and have lab space at Bonneville Labs in Berkeley.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $5.1M
- Funding stage: Seed
- Last round: Non-Equity Assistance (Jun 2023)
- Website: indeelabs.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/indee-labs-136652 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.